La cura delle persone con aids : interventi e contesti culturali / Umberto Nizzoli e Roberto Bosi |
Autore | Nizzoli, Umberto |
Pubbl/distr/stampa | Trento : Erickson, 2001 |
Descrizione fisica | 350 p. ; 24 cm |
Disciplina | 616.979206 |
Altri autori (Persone) | Bosi, Robertoauthor |
Collana | Collana di psicologia |
Soggetto topico |
AIDS - Rapporti con i pazienti - Ricerca
Sindrome da immunodeficenza acquisita - Terapia |
ISBN | 8879463993 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ita |
Record Nr. | UNISALENTO-991000503069707536 |
Nizzoli, Umberto
![]() |
||
Trento : Erickson, 2001 | ||
![]() | ||
Lo trovi qui: Univ. del Salento | ||
|
Health of HIV infected people . Volume II, : food, nutrition and lifestyle without antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (421 p.) |
Disciplina | 616.979206 |
Soggetto topico |
AIDS (Disease) - Alternative treatment
HIV-positive persons - Health and hygiene Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Overview and Food; 1 Dietary Supplements Among People Living with HIV and Vulnerability to Medical Internet Misinformation; 1.1 Section 1: Complementary and Alternative Medicine Use Among People Living with HIV; 1.2 Section 2: Correlates of CAM Use Among People Living with HIV; 1.3 Section 3: Efficacy and Utility of CAM for People Living with HIV; 1.4 Section 4: Disclosure of CAM Use to Standard HIV Care Providers
1.5 Section 5: Seeking Information About Herbal Supplements and Other CAM1.6 Section 6: Recommendations for Patients; 1.7 Section 7: Recommendations for Providers; 1.8 Section 8: Recommendations for Researchers; 1.9 Section 9: Summary; Acknowledgment; References; 2 Eating Coffee Candy: HIV Risk at Huli Funerals; 2.1 Method; 2.2 Results: Eating Coffee and Candy at Huli Funerals; 2.3 Discussion: "Eat and Die"; 2.4 Responses; References; 3 Infant Feeding Policies and HIV; 3.1 Introduction; 3.2 To Breastfeed or Not to Breastfeed? Is That the Right Question? 3.2.1 Quantifying the Magnitude of Breastfeeding-Associated HIV Infection3.2.2 Quantifying the Magnitude of Risks Associated with Not Breastfeeding; 3.2.3 How Do the Numbers Stack Up?; 3.3 Harm Reduction Approaches; 3.3.1 Exclusive Breastfeeding; 3.3.2 Early Weaning; 3.3.3 When Is Avoidance of Breastfeeding AFASS?; 3.4 Antiretroviral Interventions Transform the Policy Arena; 3.5 Key Gaps in Infant Feeding Policies and HIV; References; 4 Alcohol Use and Food Insecurity in HIV Disease Management; 4.1 Food Insecurity and HIV Disease; 4.2 Alcohol Misuse and HIV Disease 4.3 Food and Alcohol as Competing Needs4.4 Food Insecurity, Alcohol Misuse, and HIV Disease; 4.5 HIV Treatment Adherence; 4.6 Implications for Interventions; 4.7 Conclusions; Acknowledgment; References; 5 Carotid Intima-Media Thickness and Plaque in HIV-Infected Patients on the Mediterranean Diet; 5.1 Introduction; 5.2 Ultrasound Measurement of CIMT; 5.3 Characteristics of Mediterranean Diet; 5.4 CIMT in HIV-Infected Patients; 5.5 CIMT in HIV-Infected Patients Adherent to Mediterranean Diet; References; II. Nutrition and Lifestyle 6 Nutritional Treatment Approach for ART-Naïve HIV-Infected Children6.1 Introduction; 6.1.1 Proposals and Investigations About Nutritional Approach for HIV-Infected Children; 6.2 Nutritional Treatment and Ready-to-Use Formulas; 6.2.1 Breastfeeding; 6.2.2 Weaning and Complementary Feeding; 6.3 Vitamins and Minerals; 6.3.1 Iron; 6.3.2 Zinc; 6.3.3 Vitamin A; 6.3.4 Vitamin D and Calcium; 6.3.5 Micronutrients; 6.4 Probiotics; 6.5 Conclusion; References; 7 Nutrition Therapy for HAART-Naïve HIV-Infected Patients; 7.1 Introduction; 7.2 Malnutrition and Diarrhea; 7.3 Minerals; 7.3.1 Iron; 7.3.2 Zinc 7.3.3 Selenium |
Record Nr. | UNINA-9910788287003321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume I : food, nutrition and lifestyle with antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (633 p.) |
Disciplina | 616.979206 |
Soggetto topico |
HIV-positive persons - Health and hygiene
AIDS (Disease) - Treatment Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV Infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Food and Overview; 1 Exercise and Rehabilitation; 1.1 Introduction; 1.2 Quality of Life; 1.3 Exercise and HAART; 1.3.1 Exercise Activities; 1.3.2 Rebound Exercise; 1.3.3 Studies with Rebound Exercise; 1.3.4 Precautions During Rebound Exercise; 1.3.5 Physiologic Responses Following Rebound Exercise; 1.3.6 Rebound Exercise and QoL; 1.4 Summary and Clinical Implications; References
2 Metabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)2.1 Introduction; 2.1.1 Metabolic Abnormalities; 2.1.2 Grading of Severity in Dyslipidemia and Abnormal Glucose Level; 2.1.3 Anti-HIV Drugs by Class; 2.2 HIV-Associated Metabolic Abnormalities Without ART; 2.2.1 Pathophysiology of Serum Lipid Disorders; 2.2.2 Studies on Serum Lipid Disorders; 2.2.3 Serum Glucose Disorders; 2.2.4 Pathophysiology of Serum Glucose Disorders; 2.3 HIV-Associated Metabolic Abnormalities with ART; 2.3.1 Serum Lipid Disorders; 2.3.1.1 Epidemiology 2.3.2 Protease Inhibitors2.3.2.1 Mechanisms of PIs; 2.3.2.2 Dyslipidemia and PIs; 2.3.3 Nucleoside Reverse-Transcriptase Inhibitors; 2.3.3.1 Mechanism of NRTIs; 2.3.3.2 Dyslipidemia and NRTIs; 2.3.4 Non-nucleoside Reverse-Transcriptase Inhibitors; 2.3.4.1 Mechanism of NNRTIs; 2.3.4.2 Dyslipidemia and NNRTIs; 2.3.5 Dyslipidemia and Integrase Inhibitor and CCR Antagonist; 2.3.6 Glucose Metabolism; 2.3.6.1 Epidemiology; 2.3.6.2 Studies on Glucose Metabolism; 2.3.6.3 Mechanism of Antiretroviral Drugs on Glucose Metabolism; 2.4 Conclusion; References 3 Effects of Dietary Fat Intake on Acquired Immune Deficiency Syndrome During Antiretroviral Therapy3.1 Introduction; 3.1.1 Dietary Fat Intake in Health; 3.1.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome; 3.2 Dietary Fat Intake: A Role in HIV/AIDS; 3.3 Dietary Fat Intake and HIV/AIDS: Clinical Trials; 3.4 Conclusion; References; 4 Human Immunodeficiency Virus Infection-Associated Cancer and Mycotoxins in Food; 4.1 Epidemiology of Human Immunodeficiency Virus Infection; 4.2 Pathophysiology of HIV Infection with Immune Interference 4.3 Development of Cancer in a Patient with HIV4.4 Patients with HIV and ADCs; 4.5 HIV-Infected Patients with NADCs; 4.6 Mycotoxins in Patients with HIV; References; 5 Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy; 5.1 Introduction; 5.2 Signs and Symptoms; 5.3 Transmission; 5.4 Correlation of Dietary Fats and HIV; 5.5 Diagnosis and Treatment; 5.6 Antiretroviral Therapy; 5.7 Glucose Tolerance Overview; 5.8 Saturated Fatty Acids and HIV/AIDS; 5.9 Unsaturated Fatty Acids and HIV/AIDS; 5.10 Omega-3 Fatty Acids and HIV/AIDS 5.11 HIV/AIDS and Dietary Fat Supplementation |
Record Nr. | UNINA-9910788287103321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume II, : food, nutrition and lifestyle without antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (421 p.) |
Disciplina | 616.979206 |
Soggetto topico |
AIDS (Disease) - Alternative treatment
HIV-positive persons - Health and hygiene Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Overview and Food; 1 Dietary Supplements Among People Living with HIV and Vulnerability to Medical Internet Misinformation; 1.1 Section 1: Complementary and Alternative Medicine Use Among People Living with HIV; 1.2 Section 2: Correlates of CAM Use Among People Living with HIV; 1.3 Section 3: Efficacy and Utility of CAM for People Living with HIV; 1.4 Section 4: Disclosure of CAM Use to Standard HIV Care Providers
1.5 Section 5: Seeking Information About Herbal Supplements and Other CAM1.6 Section 6: Recommendations for Patients; 1.7 Section 7: Recommendations for Providers; 1.8 Section 8: Recommendations for Researchers; 1.9 Section 9: Summary; Acknowledgment; References; 2 Eating Coffee Candy: HIV Risk at Huli Funerals; 2.1 Method; 2.2 Results: Eating Coffee and Candy at Huli Funerals; 2.3 Discussion: "Eat and Die"; 2.4 Responses; References; 3 Infant Feeding Policies and HIV; 3.1 Introduction; 3.2 To Breastfeed or Not to Breastfeed? Is That the Right Question? 3.2.1 Quantifying the Magnitude of Breastfeeding-Associated HIV Infection3.2.2 Quantifying the Magnitude of Risks Associated with Not Breastfeeding; 3.2.3 How Do the Numbers Stack Up?; 3.3 Harm Reduction Approaches; 3.3.1 Exclusive Breastfeeding; 3.3.2 Early Weaning; 3.3.3 When Is Avoidance of Breastfeeding AFASS?; 3.4 Antiretroviral Interventions Transform the Policy Arena; 3.5 Key Gaps in Infant Feeding Policies and HIV; References; 4 Alcohol Use and Food Insecurity in HIV Disease Management; 4.1 Food Insecurity and HIV Disease; 4.2 Alcohol Misuse and HIV Disease 4.3 Food and Alcohol as Competing Needs4.4 Food Insecurity, Alcohol Misuse, and HIV Disease; 4.5 HIV Treatment Adherence; 4.6 Implications for Interventions; 4.7 Conclusions; Acknowledgment; References; 5 Carotid Intima-Media Thickness and Plaque in HIV-Infected Patients on the Mediterranean Diet; 5.1 Introduction; 5.2 Ultrasound Measurement of CIMT; 5.3 Characteristics of Mediterranean Diet; 5.4 CIMT in HIV-Infected Patients; 5.5 CIMT in HIV-Infected Patients Adherent to Mediterranean Diet; References; II. Nutrition and Lifestyle 6 Nutritional Treatment Approach for ART-Naïve HIV-Infected Children6.1 Introduction; 6.1.1 Proposals and Investigations About Nutritional Approach for HIV-Infected Children; 6.2 Nutritional Treatment and Ready-to-Use Formulas; 6.2.1 Breastfeeding; 6.2.2 Weaning and Complementary Feeding; 6.3 Vitamins and Minerals; 6.3.1 Iron; 6.3.2 Zinc; 6.3.3 Vitamin A; 6.3.4 Vitamin D and Calcium; 6.3.5 Micronutrients; 6.4 Probiotics; 6.5 Conclusion; References; 7 Nutrition Therapy for HAART-Naïve HIV-Infected Patients; 7.1 Introduction; 7.2 Malnutrition and Diarrhea; 7.3 Minerals; 7.3.1 Iron; 7.3.2 Zinc 7.3.3 Selenium |
Record Nr. | UNINA-9910828099603321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume I : food, nutrition and lifestyle with antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (633 p.) |
Disciplina | 616.979206 |
Soggetto topico |
HIV-positive persons - Health and hygiene
AIDS (Disease) - Treatment Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV Infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Food and Overview; 1 Exercise and Rehabilitation; 1.1 Introduction; 1.2 Quality of Life; 1.3 Exercise and HAART; 1.3.1 Exercise Activities; 1.3.2 Rebound Exercise; 1.3.3 Studies with Rebound Exercise; 1.3.4 Precautions During Rebound Exercise; 1.3.5 Physiologic Responses Following Rebound Exercise; 1.3.6 Rebound Exercise and QoL; 1.4 Summary and Clinical Implications; References
2 Metabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)2.1 Introduction; 2.1.1 Metabolic Abnormalities; 2.1.2 Grading of Severity in Dyslipidemia and Abnormal Glucose Level; 2.1.3 Anti-HIV Drugs by Class; 2.2 HIV-Associated Metabolic Abnormalities Without ART; 2.2.1 Pathophysiology of Serum Lipid Disorders; 2.2.2 Studies on Serum Lipid Disorders; 2.2.3 Serum Glucose Disorders; 2.2.4 Pathophysiology of Serum Glucose Disorders; 2.3 HIV-Associated Metabolic Abnormalities with ART; 2.3.1 Serum Lipid Disorders; 2.3.1.1 Epidemiology 2.3.2 Protease Inhibitors2.3.2.1 Mechanisms of PIs; 2.3.2.2 Dyslipidemia and PIs; 2.3.3 Nucleoside Reverse-Transcriptase Inhibitors; 2.3.3.1 Mechanism of NRTIs; 2.3.3.2 Dyslipidemia and NRTIs; 2.3.4 Non-nucleoside Reverse-Transcriptase Inhibitors; 2.3.4.1 Mechanism of NNRTIs; 2.3.4.2 Dyslipidemia and NNRTIs; 2.3.5 Dyslipidemia and Integrase Inhibitor and CCR Antagonist; 2.3.6 Glucose Metabolism; 2.3.6.1 Epidemiology; 2.3.6.2 Studies on Glucose Metabolism; 2.3.6.3 Mechanism of Antiretroviral Drugs on Glucose Metabolism; 2.4 Conclusion; References 3 Effects of Dietary Fat Intake on Acquired Immune Deficiency Syndrome During Antiretroviral Therapy3.1 Introduction; 3.1.1 Dietary Fat Intake in Health; 3.1.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome; 3.2 Dietary Fat Intake: A Role in HIV/AIDS; 3.3 Dietary Fat Intake and HIV/AIDS: Clinical Trials; 3.4 Conclusion; References; 4 Human Immunodeficiency Virus Infection-Associated Cancer and Mycotoxins in Food; 4.1 Epidemiology of Human Immunodeficiency Virus Infection; 4.2 Pathophysiology of HIV Infection with Immune Interference 4.3 Development of Cancer in a Patient with HIV4.4 Patients with HIV and ADCs; 4.5 HIV-Infected Patients with NADCs; 4.6 Mycotoxins in Patients with HIV; References; 5 Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy; 5.1 Introduction; 5.2 Signs and Symptoms; 5.3 Transmission; 5.4 Correlation of Dietary Fats and HIV; 5.5 Diagnosis and Treatment; 5.6 Antiretroviral Therapy; 5.7 Glucose Tolerance Overview; 5.8 Saturated Fatty Acids and HIV/AIDS; 5.9 Unsaturated Fatty Acids and HIV/AIDS; 5.10 Omega-3 Fatty Acids and HIV/AIDS 5.11 HIV/AIDS and Dietary Fat Supplementation |
Record Nr. | UNINA-9910828099703321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
HIV treatments as prevention (TasP) : primer for behavior-based implementation / / Seth C. Kalichman |
Autore | Kalichman Seth C |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | New York, : Springer, 2013 |
Descrizione fisica | 1 online resource (140 p.) |
Disciplina | 616.979206 |
Collana | SpringerBriefs in public health |
Soggetto topico |
HIV infections - Prevention
HIV infections - Treatment AIDS (Disease) - Prevention |
ISBN |
1-283-62471-0
9786613937162 1-4614-5119-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1: Foundations and Principles -- Chapter 2: Reflecting on Prevention Technologies -- Chapter 3: The TasP Revolution -- Chapter 4: Ressource: In the Mix Intervention Manual. . |
Record Nr. | UNINA-9910438127303321 |
Kalichman Seth C
![]() |
||
New York, : Springer, 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design : A Review of 20 Years of Research / / by Marc H V Van Regenmortel |
Autore | Van Regenmortel Marc H V |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (379 pages) |
Disciplina |
616.979206
616.9792 |
Soggetto topico |
Vaccines
Virology Vaccine VIH (Virus) |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-32459-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I.Immunochemistry -- 1 What is a B cell epitope -- 2 Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure–function relationships in immunology -- 3 Synthetic Peptide Vaccines and the Search for Neutralization B Cell Epitopes -- 4 Specificity, polyspecificity, and heterospecificity of antibody‐antigen recognition -- Part II. Reductionism -- 5 Reductionism and the search for structure–function relationships in antibody molecules -- 6 Reductionism and complexity in molecular biology -- 7 Editorial: Biological complexity emerges from the ashes of genetic reductionism -- 8 The rational design of biological complexity: A deceptive metaphor., 9 Basic research in HIV vaccinology is hampered by reductionist thinking -- 10 Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking -- 11 Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases., Part III. Vaccinology -- 12 Limitations to the structure‐based design of HIV‐1 vaccine immunogens -- 13 Two meanings of reverse vaccinology and the empirical nature of vaccine science -- 14 Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine -- 15 Paradigm Changes and the Future of HIV Vaccine Research: A Summary of a Workshop Held in Baltimore on 20 November 2013 -- 16 Editorial: Paradigm changes are required in HIV vaccine research -- 17 An outdated notion of antibody specificity is one of the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from helping to develop an effective HIV-1 vaccine -- 18 More surprises in the development of an HIV vaccine -- 19 Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine? -- 20 Old and New Concepts and Strategies in HIV Vaccinology: A Report from a Workshop held in Rome on 17 June 2016 -- 21 Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory -- 22 Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV -- 23 Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design -- 24 Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia? |
Record Nr. | UNINA-9910373909003321 |
Van Regenmortel Marc H V
![]() |
||
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|